Cita APA (7a ed.)
Ouerdani, A., Valenzuela, B., Treijtel, N., Haddish-Berhane, N., Desphande, S., Srinivasan, S., . . . Perez Ruixo, J. J. (2025). Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL). Cancer Chemotherapy & Pharmacology, 95(1), 1-12.
Cita Chicago Style (17a ed.)
Ouerdani, Aziz, Belén Valenzuela, Nicoline Treijtel, Nahor Haddish-Berhane, Sanjay Desphande, Srimathi Srinivasan, Emma Smith, y Juan José Perez Ruixo. "Evaluation of Bruton's Tyrosine Kinase (BTK) Inhibition with Alternative Doses of Ibrutinib in Subjects with Chronic Lymphocytic Leukemia (CLL)." Cancer Chemotherapy & Pharmacology 95, no. 1 (2025): 1-12.
Cita MLA (9a ed.)
Ouerdani, Aziz, et al. "Evaluation of Bruton's Tyrosine Kinase (BTK) Inhibition with Alternative Doses of Ibrutinib in Subjects with Chronic Lymphocytic Leukemia (CLL)." Cancer Chemotherapy & Pharmacology, vol. 95, no. 1, 2025, pp. 1-12.
Precaución: Estas citas no son 100% exactas.